Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study
المؤلفون المشاركون
Pompili, Maurizio
Corigliano, Valentina
Comparelli, Anna
Mancinelli, Iginia
Montalbani, Benedetta
Lamis, Dorian A.
De Carolis, Antonella
Erbuto, Denise
Girardi, Paolo
المصدر
Schizophrenia Research and Treatment
العدد
المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-7، 7ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2018-08-30
دولة النشر
مصر
عدد الصفحات
7
التخصصات الرئيسية
الملخص EN
Long-acting injectable second-generation antipsychotics (LAI-SGA) are typically used to maintain treatment adherence in patients with chronic schizophrenia.
Recent research suggests that they may also provide an effective treatment strategy for patients with early-phase disease.
The aim of this study is to evaluate clinical and psychosocial outcomes among recent and long-term diagnosed schizophrenia outpatients treated with LAI-SGA during a follow-up period of 12 months.
Stable schizophrenia patients receiving LAI-SGA with 5 or less years of illness duration (n = 10) were compared to those with more than 5 years of illness duration (n = 15).
Clinical data was assessed through the Positive and Negative Syndrome Scale (PANSS), the Global Assessment of Functioning (GAF), the Columbia Suicide Severity Rating Scale (C-SSRS), the Recovery Style Questionnaire (RSQ), and the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) Managing Emotion branch.
Recently diagnosed patients showed greater improvement versus patients diagnosed for more than 5 years in adjusted mean GAF score, in PANSS factor score for negative and depressive symptoms, and in severity and intensity of suicidal ideation.
Our preliminary findings support the hypothesis that LAI-SGA may influence the course of the illness if administered at the early phase of the illness.
However, replicate studies are needed, possibly with larger samples.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Corigliano, Valentina& Comparelli, Anna& Mancinelli, Iginia& Montalbani, Benedetta& Lamis, Dorian A.& De Carolis, Antonella…[et al.]. 2018. Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study. Schizophrenia Research and Treatment،Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1213046
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Corigliano, Valentina…[et al.]. Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study. Schizophrenia Research and Treatment No. 2018 (2018), pp.1-7.
https://search.emarefa.net/detail/BIM-1213046
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Corigliano, Valentina& Comparelli, Anna& Mancinelli, Iginia& Montalbani, Benedetta& Lamis, Dorian A.& De Carolis, Antonella…[et al.]. Long-Acting Injectable Second-Generation Antipsychotics Improve Negative Symptoms and Suicidal Ideation in Recent Diagnosed Schizophrenia Patients: A 1-Year Follow-up Pilot Study. Schizophrenia Research and Treatment. 2018. Vol. 2018, no. 2018, pp.1-7.
https://search.emarefa.net/detail/BIM-1213046
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1213046
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر